✦ LIBER ✦

PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder

✍ Scribed by T.R. Einarson; R. Jensen; M. Hemels

Book ID: 119312747
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.794

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of lon

Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder

✍ Jean-Pierre Lindenmayer; Akbar Khan; Mariëlle Eerdekens; Ilse Van Hove; Stuart K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 443 KB

Remission in schizophrenia: one-year Ita

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder

✍ Alessandro Rossi; Anna Bagalà; Vincenzo Del Curatolo; Francesco Scapati; Micaela 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract ## Objectives To evaluate the maintenance of efficacy of risperidone long‐acting injectable (RLAI) in stable patients with schizophrenia or schizoaffective disorders. The prevalence of patients who met standardized remission criteria will be also evaluated as well as the predictors fac

A cost-consequence analysis of long-acti

A cost-consequence analysis of long-acting injectable risperidone in schizophrenia: A one-year mirror-image study with national claim-based database in Taiwan

✍ Hui-Chih Chang; Chao-Hsiun Tang; Sheng-Tzu Huang; Paul McCrone; Kuan-Pin Su 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

PMH18 HEALTH CARE RESOURCE UTILIZATION A

PMH18 HEALTH CARE RESOURCE UTILIZATION ANALYSIS OF PRE/POST LONG-ACTING RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS IN THREE REGIONAL PUBLIC HOSPITALS IN HONG KONG

✍ KK Lee; EH Lee; VWY Lee; DW Chung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

P.3.c.006 Safety and efficacy of olanzap

P.3.c.006 Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder

✍ D.P. McDonnell; H.C. Detke; M. Choukour; J. Landry 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

PMH41 RISPERIDONE LONG ACTING INJECTION

PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA: INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

✍ JM Olivares; TJR Lambert; J Peuskens; S Caleo; M Povey; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB